Kangji Medical Holdings Limited
SZSC:9997 주식 보고서
Kangji Medical Holdings 과거 수익 실적 Kangji Medical Holdings은 연평균 21.5%의 비율로 수입이 증가해 온 반면, Medical Equipment 산업은 수입이 증가했으며, 연간 14.7%였습니다. 매출은 연평균 15.5%의 비율로 증가했습니다. Kangji Medical Holdings의 자기자본이익률은 21.1%이고 순이익률은 54.5%입니다.
주요 정보 Medical Equipment 산업 성장 13.7% 매출 성장률 15.5% 자기자본 수익률 21.1% 순이익 54.5% 최근 수익 업데이트 30 Jun 2024
최근 과거 실적 업데이트
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Sep 27
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2024 Results on Aug 20, 2024 Aug 06
Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.40 in FY 2022) Apr 30
First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022) Aug 31
Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023 Aug 09
모든 업데이트 표시
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Sep 27
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2024 Results on Aug 20, 2024 Aug 06 Kangji Medical Holdings Limited Approves Special Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024
Investor sentiment deteriorates as stock falls 26% May 29
Upcoming dividend of CN¥1.40 per share May 22
Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.40 in FY 2022) Apr 30
Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023 Apr 26
Dividend of CN¥1.40 announced Mar 22 Kangji Medical Holdings Limited, Annual General Meeting, May 27, 2024
Investor sentiment improves as stock rises 17% Nov 08
Kangji Medical Holdings Limited Announces CFO Changes Sep 06 Kangji Medical Holdings Limited Announces the Resignation of Frances Fang Chovanec as Executive Director, Member of Environmental, Social and Governance Committee with Effective from September 15, 2023
First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022) Aug 31
Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023 Aug 09
Now 21% undervalued after recent price drop Aug 01
Now 22% undervalued after recent price drop Jul 05
Now 20% undervalued after recent price drop Jun 12
Kangji Medical Holdings Limited Approves Payment of Final Dividend for the Year Ended December 31, 2022, Payment Date Is 10 July 2023 May 26
Full year 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.37 in FY 2021) Mar 29
Investor sentiment improved over the past week Jan 16
Less than half of directors are independent Nov 16
First half 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.16 in 1H 2021) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022 Aug 03
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021, Payment date is 08 July 2022 May 27
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021 May 26
Upcoming dividend of HK$0.17 per share May 20
Kangji Medical Holdings Limited Announces Executive Changes May 04
Full year 2021 earnings released: EPS: CN¥0.37 (vs CN¥0.26 in FY 2020) May 03
Less than half of directors are independent Apr 27
Kangji Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 22, 2022 Mar 03
Investor sentiment deteriorated over the past week Dec 07
Investor sentiment improved over the past week Sep 02
First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.12 in 1H 2020) Aug 29
Investor sentiment improved over the past week Aug 03
Investor sentiment improved over the past week Jul 16
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2020 May 27
Investor sentiment improved over the past week May 17
Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.20 in FY 2019) Apr 28
Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2020 Apr 27
Investor sentiment improved over the past week Apr 24
Full year 2020 earnings released Mar 26
Kangji Medical Holdings Limited to Report Fiscal Year 2020 Results on Mar 25, 2021 Mar 13
Investor sentiment deteriorated over the past week Feb 27
New 90-day low: HK$10.88 Feb 27
Investor sentiment deteriorated over the past week Jan 29
New 90-day low: HK$12.16 Jan 28
Investor sentiment deteriorated over the past week Dec 24
New 90-day low: HK$13.86 Dec 09
Market pulls back on stock over the past week Nov 26
Kangji Medical Holdings Limited Appoints Frances Fang Chovanec as Executive Director Nov 06
First half earnings released Sep 22
Kangji Medical Holdings 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역 SZSC:9997 수익, 비용 및 수입 (CNY Millions ) 날짜 수익 수익 G+A 비용 R&D 비용 30 Jun 24 981 534 181 111 31 Mar 24 953 519 176 119 31 Dec 23 926 504 171 128 30 Sep 23 892 540 158 114 30 Jun 23 858 576 146 100 31 Mar 23 822 528 135 83 31 Dec 22 786 479 124 66 30 Sep 22 745 447 122 56 30 Jun 22 704 415 120 46 31 Mar 22 697 436 115 41 31 Dec 21 690 457 109 36 30 Sep 21 654 413 103 33 30 Jun 21 617 369 96 29 31 Mar 21 564 310 95 27 31 Dec 20 511 250 95 25 30 Sep 20 506 227 88 23 30 Jun 20 500 204 81 21 31 Mar 20 502 205 74 19 31 Dec 19 503 206 67 17 31 Dec 18 354 147 43 15 31 Dec 17 248 118 29 10
양질의 수익: 9997 은 높은 수익 을 보유하고 있습니다.
이익 마진 증가: 9997 의 현재 순이익 이익률 (54.5%) 작년보다 낮습니다 (67.2%).
과거 수익 성장 분석
수익추이: 9997 의 수익은 지난 5년 동안 매년 21.5% 씩 크게 증가했습니다.
성장 가속화: 9997 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.
수익 대 산업: 9997 은 지난 1년 동안 마이너스 수익 성장( -7.3% )을 기록하여 Medical Equipment 업계 평균( -4.3% ).
자기자본 수익률
높은 ROE: 9997 의 자본 수익률 ( 21.1% )은 높음 으로 간주됩니다.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":false,"variant":{"name":"disabled","enabled":false},"flagsReady":false,"flagsError":null}